United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

MHRA Launches Consultation On Modernising The Definition Of Gene Therapy Medicinal Products

The MHRA has launched a consultation on proposed updates to the definition of gene therapy medicinal products (“GTMPs”) under the UK Human Medicines Regulations 2012 (“HMRs”).

United Kingdom Healthcare

AP

Arnold & Porter

Battery Recycling And Reuse Technologies Drive Patent Growth

As set out in the EPO’s recently-released Technology Dashboard 2025 (its annual summary of key figures and trends in patent activity), growth in the field of battery technologies continues unabated, with the number...

M

Murgitroyd

London X China Podcast Series - Episode 7: Trends In Global Pharma M&A

This podcast focuses on the pharmaceutical industry and, in particular, M&A activity in the sector and the recent surge in licensing deals involving Chinese biotechs.

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

UPC Court Of Appeal Endorses EPO Approach To Inventive Step For Computer-Implemented Inventions

In Abbott v Sinocare, UPC_CoA_901/2025, 17 April 2026, the UPC Court of Appeal endorsed the EPO approach to assessing inventive step for computer-implemented inventions.

United Kingdom IP

JA

J A Kemp LLP

New PMAC Model Clauses: Position Your IP Agreements For The UPC Era

United Kingdom IP

GW

Gowling WLG

Draft UK Medical Device Amending Regulations: Key Proposals And MHRA Call For Evidence

Worldwide Healthcare

AP

Arnold & Porter

Impact Beyond Orbcit - The Breadth Of Value Of Space Technology

United Kingdom IP

MC

Marks & Clerk

The New UK Clinical Trials Regulations: Where Does The New Law Leave Injured Trial Participants?

United Kingdom Litigation

AG

Anthony Gold Solicitors LLP

Launching The Latest Edition Of Our Life Sciences And Healthcare Insights

United Kingdom Healthcare

AO

A&O Shearman

Navigating IVD Regulation In Clinical Trials: A Comparative EU And UK Guide

European Union Healthcare

AP

Arnold & Porter

The Never-ending Licence That Ended: Court Of Appeal Clarifies Licence Termination Rights

United Kingdom IP

GW

Gowling WLG

Stacked: The New Shape Of The Supplement Industry

United Kingdom Healthcare

A

AlixPartners

EU General Court: Technical Vaccine Data Does Not Have To Be Disclosed On Request

United Kingdom Healthcare

A

Altius

Pharma: Key UK Legal Developments From 2025

Worldwide Healthcare

KL

Herbert Smith Freehills Kramer LLP

A Global View Of International Arbitration Trends With Gary Born (Podcast)

United Kingdom Litigation

W

WilmerHale

FinTech Global FS Regulatory Round-up - W/e 24 April 2026

Worldwide Technology

KL

Herbert Smith Freehills Kramer LLP

A Global View Of International Arbitration Trends With Gary Born (Video)

United Kingdom Litigation

W

WilmerHale

Biannual Banking Litigation Update (Spring 2026) (Video)

United Kingdom Finance

KL

Herbert Smith Freehills Kramer LLP

From Soil To Shares: Professional Advisor Guidance For Farm Divorce (Video)

United Kingdom Family

LL

Lerners LLP

Listing And Prospectus Regime – FCA Consultation On Miscellaneous Amendments

The FCA has published its latest Quarterly Consultation Paper No. 51 (CP26/8) which includes proposals to amend the notification requirements under the UKLRs...

United Kingdom Commercial

KL

Herbert Smith Freehills Kramer LLP

Snapshot: Key European Pharma Regulatory, IP And Competition Developments From 2025 For The Pharmaceutical Sector

In this blog post, experts from across our pharma regulatory, IP and competition teams provide a brief snapshot of some of the key European developments which companies in the pharma sector should be aware of.

European Union Healthcare

KL

Herbert Smith Freehills Kramer LLP

Provisional Text Of The Political Agreement On The Reform To The EU Regulatory Framework For Medicinal Products Is Published

Today, 6 March 2026, the Council of the European Union ("Council") published the provisional agreement on the reform of the EU...

United Kingdom Healthcare

AP

Arnold & Porter

'WHOOP WHOOP' - A Wearable Focused On Women's Health

WHOOP, the fitness wearable maker, have just announced the launch of a new blood test biomarker package designed to aid in the tracking of women's health, called the Women's Health Specialized Blood Biomarker Panel...

United Kingdom Healthcare

MC

Marks & Clerk

Virtual And Digital Health Digest – February 2026

United Kingdom Healthcare

AP

Arnold & Porter

Changes To UK Clinical Trials Regulations Take Effect April 28, 2026. New Versions Of UK Model Clinical Trial Agreement Forms Pending

United Kingdom Healthcare

CM

Crowell & Moring LLP

New Injectable Bandages To Reduce Bleed Time By Almost 70%

United Kingdom IP

MC

Marks & Clerk

Five Governance Essentials To Reduce False Claims Act Risk

United Kingdom Commercial

A

AlixPartners

An IP Guide To Biosimilars

United Kingdom IP

B

Boult Wade Tennant

UK Government Sets Out 2026 Branded Medicines Statutory Scheme Repayment Rate

United Kingdom Healthcare

AP

Arnold & Porter

Healthcare & Life Sciences – AI Readiness & Integration Questionnaire

United Kingdom Healthcare

AG

Addleshaw Goddard

UK PMCPA Releases New Guidance On Package Deals: Key Takeaways For Industry

United Kingdom Healthcare

AP

Arnold & Porter

UK's Data (Use And Access) Act: What Life Sciences Companies Need To Know

United Kingdom Healthcare

AP

Arnold & Porter

Is Change On The Horizon For The UK Product Liability Regime? [Updated]

United Kingdom Healthcare

AP

Arnold & Porter

Healthcare & Life Sciences – AI Readiness & Integration Questionnaire

Artificial Intelligence (AI) is rapidly changing the way people work across the life sciences and healthcare sector.

United Kingdom Healthcare

AG

Addleshaw Goddard

UK PMCPA Releases New Guidance On Package Deals: Key Takeaways For Industry

The Prescription Medicines Code of Practice Authority (PMCPA) has published new guidance to provide clarity on the disclosure obligations and commercial governance expected from companies in relation to package deals (Guidance).

United Kingdom Healthcare

AP

Arnold & Porter

UK's Data (Use And Access) Act: What Life Sciences Companies Need To Know

The Data (Use and Access) Act 2025 ("DUAA") represents the UK's first major reform of data protection law since leaving the EU.

United Kingdom Healthcare

AP

Arnold & Porter

Is Change On The Horizon For The UK Product Liability Regime? [Updated]

The Law Commission, an independent organisation established to keep the law of England & Wales under review and recommend reform, has announced a review of the law in relation to liability for defective products.

United Kingdom Healthcare

AP

Arnold & Porter

European Real Estate: A Market Ready To Mobilize

European Union Real Estate

SR

McDermott Will & Schulte

UK Government To Issue Guidance On Industry Payment Transparency

Following a public consultation, the UK government has outlined plans to publish guidance on disclosing payments made by the medicines and medical devices industries to the healthcare sector.

United Kingdom Healthcare

AP

Arnold & Porter

Celltrion And Sandoz Launch Their Aflibercept Biosimilars In Europe

On November 27, 2025, Celltrion announced that Health Canada approved EYDENZELT® (aflibercept-boav), a biosimilar referencing Regeneron's EYLEA® (aflibercept)...

European Union Healthcare

GP

Goodwin Procter LLP

What Will 2026 Hold For Life Sciences And Biopharma?

Looking ahead to 2026, we anticipate a landscape defined by strategic investments, major transactions, and groundbreaking innovation.

United Kingdom Commercial

AO

A&O Shearman

European Commission Proposes Simplifying The Rules On EU Medical And In-Vitro Diagnostic Devices

The proposed simplification is intended to reduce the administrative burden on EU manufacturers of medical and in-vitro diagnostic devices and lower their compliance-related costs...

United Kingdom Healthcare

CM

Crowell & Moring LLP

M&C In The News: What's Holding Back UK Life Sciences?

United Kingdom IP

MC

Marks & Clerk

Precision Breeding In England: Navigating The New Regulatory Framework

United Kingdom Healthcare

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Updates Announced To The UK-US Trade Deal See Greater Support For The Pharmaceuticals Sector

United Kingdom International

GW

Gowling WLG

SPC Waiver: No MA? UK Says Ok

United Kingdom IP

PC

Potter Clarkson

Current Life Sciences Insurance Trends And The Imperative For Specialised Coverage

United Kingdom Healthcare

BJ

Browne Jacobson

Confidentiality In Clinical Trials: Arbitration As The Preferred Route For Dispute Resolution

United Kingdom Litigation

BJ

Browne Jacobson

Climate Resilient Crops – Mitigating The Risks Of Climate Change

United Kingdom Environment

JA

J A Kemp LLP

Cross-border Collaboration In Life Sciences: How To Make It Work

Worldwide Healthcare

BJ

Browne Jacobson

Unlocking Value Creation In Healthcare: How AI Can Reverse Private Equity's Return Challenges - Part 1: HealthTech And Tech-enabled Services

United Kingdom Healthcare

A

AlixPartners

Hot Topics: Life Sciences - October 2025

United Kingdom Healthcare

AG

Addleshaw Goddard

How MHRA's International Reliance Is Shaping UK Medicine Regulation

United Kingdom Healthcare

BJ

Browne Jacobson

Technology-Enabled Care In The UK: Legal And Technical Developments To Watch

United Kingdom Healthcare

BJ

Browne Jacobson

The Dog That Barks: The UK's CMA Is Proposing Major Reforms To Veterinary Businesses

United Kingdom Healthcare

AP

Arnold & Porter

Arbitrating Innovation: Resolving IP Disputes In The Life Sciences Sector

United Kingdom Healthcare

BJ

Browne Jacobson

The Importance Of AI In The Development Life Sciences

United Kingdom Healthcare

BJ

Browne Jacobson

See more

Latest Videos

See more

Brexit And Data Privacy (Video)

AP

Arnold & Porter

Legally Vocal: Patrick Duxbury On His COVID-19 Vaccine Work And 20-Year Career In Life Sciences (Video)

GW

Gowling WLG

Webinar: Supplementary Protection Certificates - Part Two (Video)

D

Dehns

Claim One – #01 EPO Oral Proceedings (Video)

H

HLK

Deloitte Global TMT Predictions 2018 Machine Learning (Video)

D

Deloitte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More